Similar articles

• Benefits of atorvastatin in cholesterol lowering.

  Farmer JA. Farmer JA. Curr Atheroscler Rep. 2003 Mar;5(2):94-5. Curr Atheroscler Rep. 2003. PMID: 12573192 No abstract available.
• [Atorvastatin].

  Kajinami K, Takekoshi N. Kajinami K, et al. Nihon Rinsho. 2001 Mar;59 Suppl 3:598-604. Nihon Rinsho. 2001. PMID: 11347138 Review. Japanese. No abstract available.
• [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Aug 18;147(33-34):51. MMW Fortschr Med. 2005. PMID: 16138641 German. No abstract available.
• Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).

  Tikkanen MJ, Holme I, Cater NB, Szarek M, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR; Incremental DEcrease through Aggressive Lipid Lowering Investigators. Tikkanen MJ, et al. Am J Cardiol. 2009 Mar 1;103(5):577-82. doi: 10.1016/j.amjcard.2008.10.029. Epub 2009 Jan 17. Am J Cardiol. 2009. PMID: 19231315 Clinical Trial.
• Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.

  Waters D. Waters D. Eur Heart J. 2000 Jul;21(13):1029-31. doi: 10.1053/euhj.1999.2015. Eur Heart J. 2000. PMID: 10843815 Review. No abstract available.